English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90453/105671 (86%)
Visitors : 15988813      Online Users : 158
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/64326


    Title: Andrographis paniculata Extract and Andrographolide Modulate the Hepatic Drug Metabolism System and Plasma Tolbutamide Concentrations in Rats
    Authors: Chen, HW;Chen, HW;黃晉修;Huang, Chin-Shiu;Liu, PF;Liu, PF;Li, CC;Li, CC;Chen, CT;Chen, CT;Liu, CT;Liu, CT;Chiang, JR;Chiang, JR;Yao, HT;Yao, HT;李宗貴;Lii, Chong-Kuei
    Contributors: 保健營養生技學系
    Keywords: CONSTITUTIVE ANDROSTANE RECEPTOR;GLUTATHIONE-S-TRANSFERASE;MESSENGER-RNA EXPRESSION;PREGNANE X RECEPTOR;PHASE-II ENZYMES;ACTIVE DITERPENOIDS;SIGNALING PATHWAY;LIVER-MICROSOMES;DIABETIC-RATS;IN-VITRO
    Date: 201308
    Issue Date: 2013-10-29 17:37:32 (UTC+8)
    Abstract: Andrographolide is the most abundant terpenoid of A. paniculata which is used in the treatment of diabetes. In this study, we investigated the effects of A. paniculata extract (APE) and andrographolide on the expression of drug-metabolizing enzymes in rat liver and determined whether modulation of these enzymes changed the pharmacokinetics of tolbutamide. Rats were intragastrically dosed with 2 g/kg/day APE or 50 mg/kg/day andrographolide for 5 days before a dose of 20 mg/kg tolbutamide was given. APE and andrographolide reduced the AUC0-12 h of tolbutamide by 37% and 18%, respectively, compared with that in controls. The protein and mRNA levels and enzyme activities of CYP2C6/11, CYP1A1/2, and CYP3A1/2 were increased by APE and andrographolide. To evaluate whether APE or andrographolide affected the hypoglycemic action of tolbutamide, high-fat diet-induced obese mice were used and treated in the same manner as the rats. APE and andrographolide increased CYP2C6/11 expression and decreased plasma tolbutamide levels. In a glucose tolerance test, however, the hypoglycemic effect of tolbutamide was not changed by APE or andrographolide. These results suggest that APE and andrographolide accelerate the metabolism rate of tolbutamide through increased expression and activity of drug-metabolizing enzymes. APE and andrographolide, however, do not impair the hypoglycemic effect of tolbutamide.
    Relation: Evidence-based Complementary and Alternative Medicine, 2013:982689.
    Appears in Collections:[食品營養與保健生技學系] 期刊論文

    Files in This Item:

    File SizeFormat
    index.html0KbHTML454View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback